Genetic Technologies Limited announced this week the successful completion of two ground-breaking tests branded GeneType for Colorectal Cancer and GeneType for Breast Cancer. The two new tests follow substantial scientific research and genetic product development. According to the company’s press release, the company’s “polygenic risk tests combine information from genetic markers called Single Nucleotide Polymorphisms … Continue reading “Genetic Technologies Limited Announces Completion of Two Genetic Risk Tests for Colorectal Cancer and Breast Cancer”
